• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Enliven Therapeutics, Inc. - Common Stock (NQ: ELVN )

    27.36 +1.82 (+7.13%)
    Streaming Delayed Price Updated: 12:38 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 220,570
    Open 25.70
    Bid (Size) 27.20 (3)
    Ask (Size) 27.39 (3)
    Prev. Close 25.54
    Today's Range 24.93 - 27.55
    52wk Range 9.800 - 27.67
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
    HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwright gave a Buy rating with a $37 price target, projecting significant... 
    Via Benzinga
    ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024
    ELVN stock results show that Enliven Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +83.62%
    +83.62%
    1 Month
    +23.24%
    +23.24%
    3 Month
    +20.53%
    +20.53%
    6 Month
    +44.76%
    +44.76%
    1 Year
    +100.00%
    +100.00%

    More News

    Read More
    ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
    Via Benzinga
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
    Via Benzinga
    Wall Street Mixed As Tech Stocks Fall, Fed Meeting Begins
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    7 A-Rated Biotech Stocks for Your August Buy List
    Via InvestorPlace
    Bears Reload On Mobileye After Sharp Gains In Stock Price
    Via Talk Markets
    Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
    Via Benzinga
    7 Biotech Stocks Sitting in the Sweet Spot
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.